Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Robbins

Showing results (121-130 of 223) with videos related to

Pageof 23
Sort By:
Infection and Immunity|August 1, 1995
Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemesR K Gupta, W Egan, D A Bryla, et al.
Bulletin of the World Health Organization|January 1, 1983
Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78N Guirguis, K Hafez, M A El Kholy, et al.
Infection and Immunity|October 1, 1989
Characterization of the Salmonella paratyphi C Vi polysaccharideE M Daniels, R Schneerson, W M Egan, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
The Journal of Infectious Diseases|April 1, 1976
Host factors and antibody response Haemophilus influenza type b meningitis and epiglottitisJ K Whisnant, G N Rogentine, M A Gralnick, et al.
Vaccine|January 1, 1994
Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccinesW A Keitel, N L Bond, J M Zahradnik, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
The Journal of Infectious Diseases|June 1, 1992
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infectionA Casadevall, J Mukherjee, S J Devi, et al.
Infection and Immunity|June 25, 1998
Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteersR K Gupta, D N Taylor, D A Bryla, et al.
Pageof 23

Showing results (121-130 of 223) with videos related to

Sort By:
Pageof 23
Infection and Immunity|August 1, 1995
Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemesR K Gupta, W Egan, D A Bryla, et al.
Bulletin of the World Health Organization|January 1, 1983
Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78N Guirguis, K Hafez, M A El Kholy, et al.
Infection and Immunity|October 1, 1989
Characterization of the Salmonella paratyphi C Vi polysaccharideE M Daniels, R Schneerson, W M Egan, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
The Journal of Infectious Diseases|April 1, 1976
Host factors and antibody response Haemophilus influenza type b meningitis and epiglottitisJ K Whisnant, G N Rogentine, M A Gralnick, et al.
Vaccine|January 1, 1994
Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccinesW A Keitel, N L Bond, J M Zahradnik, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
The Journal of Infectious Diseases|June 1, 1992
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infectionA Casadevall, J Mukherjee, S J Devi, et al.
Infection and Immunity|June 25, 1998
Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteersR K Gupta, D N Taylor, D A Bryla, et al.
Pageof 23